GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Illumina, Inc. (ILMN) [hlAlert]

Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping
and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company?s subsidiary is Solexa, Inc.
.
( Total: 34 Current Stock Recommendations )
Illumina, Inc.   (34)
Sell Hold 29% Buy 68%
Related companies
Roper Industries, ...   (17)
Sell Hold 29% Buy 65%
Pall Corporation   (9)
Sell Hold 56% Buy 33%
Thermo Fisher ...   (23)
Hold Buy 91%
Danaher Corporation   (31)
Hold 19% Buy 81%
Waters Corporation   (29)
Hold 62% Buy 38%
Filter by Gains:   
  
Rating:
Hold ILMN

Rating:
Hold ILMN

Rating:
Buy ILMN
up 45.84 %

Rating:
Hold ILMN

Rating:
Buy ILMN
up 6.70 %

Rating:
Hold ILMN
down 10.31 %

Rating:
Hold ILMN
Illumina, Inc. (ILMN) rated Mkt Perform by Leerink Partners
Thursday,  Oct 1, 2015  10:25 AM ET

Rating:
Buy ILMN
down 4.21 %

Rating:
Buy ILMN

Rating:
Buy ILMN
down 0.32 %

Rating:
Buy ILMN
up 6.70 %
Illumina, Inc. (ILMN) rated Buy with price target $235 by Stifel
Wednesday,  Jan 28, 2015  9:25 AM ET

Rating:
Buy ILMN
up 170.11 %

Rating:
Buy ILMN
up 6.70 %

Rating:
Buy ILMN
up 25.52 %
Illumina, Inc. (ILMN) rated Buy by Tigress Financial
Friday,  Aug 1, 2014  12:00 AM ET

Rating:
Buy ILMN
up 31.39 %

Your Recent Stocks
SymbolLastChange
ILMN 132.90 down  -34.18 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy